225 related articles for article (PubMed ID: 22914404)
1. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
Grimm C; Polterauer S; Natter C; Rahhal J; Hefler L; Tempfer CB; Heinze G; Stary G; Reinthaller A; Speiser P
Obstet Gynecol; 2012 Jul; 120(1):152-9. PubMed ID: 22914404
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
de Witte CJ; van de Sande AJ; van Beekhuizen HJ; Koeneman MM; Kruse AJ; Gerestein CG
Gynecol Oncol; 2015 Nov; 139(2):377-84. PubMed ID: 26335596
[TBL] [Abstract][Full Text] [Related]
3. Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
Sheth SS; Oh JE; Bellone S; Siegel ER; Greenman M; Mutlu L; McNamara B; Pathy S; Clark M; Azodi M; Altwerger G; Andikyan V; Huang G; Ratner E; Kim DJ; Iwasaki A; Levi AW; Buza N; Hui P; Flaherty S; Schwartz PE; Santin AD
Clin Cancer Res; 2024 May; 30(9):1768-1777. PubMed ID: 38592381
[TBL] [Abstract][Full Text] [Related]
4. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
[TBL] [Abstract][Full Text] [Related]
5. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Fonseca BO; Possati-Resende JC; Salcedo MP; Schmeler KM; Accorsi GS; Fregnani JHTG; Antoniazzi M; Pantano NP; Santana IVV; Matsushita GM; Dos Reis R
Obstet Gynecol; 2021 Jun; 137(6):1043-1053. PubMed ID: 33957649
[TBL] [Abstract][Full Text] [Related]
6. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
Pachman DR; Barton DL; Clayton AC; McGovern RM; Jefferies JA; Novotny PJ; Sloan JA; Loprinzi CL; Gostout BS
Am J Obstet Gynecol; 2012 Jan; 206(1):42.e1-7. PubMed ID: 21907959
[TBL] [Abstract][Full Text] [Related]
7. TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
van de Sande AJM; Koeneman MM; Gerestein CG; Kruse AJ; van Kemenade FJ; van Beekhuizen HJ
BMC Cancer; 2018 Jun; 18(1):655. PubMed ID: 29902979
[TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
Lin CT; Qiu JT; Wang CJ; Chang SD; Tang YH; Wu PJ; Jung SM; Huang CC; Chou HH; Jao MS; Lai CH
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):533-8. PubMed ID: 23276555
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
Chen FP
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):475-8. PubMed ID: 24411029
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Desravines N; Hsu CH; Mohnot S; Sahasrabuddhe V; House M; Sauter E; O'Connor S; Bauman JE; Chow HS; Rahangdale L
Int J Gynaecol Obstet; 2023 Dec; 163(3):862-867. PubMed ID: 37431689
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
van de Sande AJM; Kengsakul M; Koeneman MM; Jozwiak M; Gerestein CG; Kruse AJ; van Esch EMG; de Vos van Steenwijk PJ; Muntinga CLP; Bramer WM; van Doorn HC; van Kemenade FJ; van Beekhuizen HJ
Int J Gynaecol Obstet; 2024 Jan; 164(1):66-74. PubMed ID: 37350560
[TBL] [Abstract][Full Text] [Related]
12. Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial.
Koeneman MM; Kruse AJ; Kooreman LF; Zur Hausen A; Hopman AH; Sep SJ; Van Gorp T; Slangen BF; van Beekhuizen HJ; van de Sande AJ; Gerestein CG; Nijman HW; Kruitwagen RF
BMC Cancer; 2017 Feb; 17(1):110. PubMed ID: 28173776
[TBL] [Abstract][Full Text] [Related]
13. Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Polterauer S; Reich O; Widschwendter A; Hadjari L; Bogner G; Reinthaller A; Joura E; Trutnovsky G; Ciresa-Koenig A; Ganhoer-Schimboeck J; Boehm I; Berger R; Langthaler E; Aberle SW; Heinze G; Gleiss A; Grimm C
Gynecol Oncol; 2022 Apr; 165(1):23-29. PubMed ID: 35177279
[TBL] [Abstract][Full Text] [Related]
14. Treatment of vulvar intraepithelial neoplasia with topical imiquimod.
van Seters M; van Beurden M; ten Kate FJ; Beckmann I; Ewing PC; Eijkemans MJ; Kagie MJ; Meijer CJ; Aaronson NK; Kleinjan A; Heijmans-Antonissen C; Zijlstra FJ; Burger MP; Helmerhorst TJ
N Engl J Med; 2008 Apr; 358(14):1465-73. PubMed ID: 18385498
[TBL] [Abstract][Full Text] [Related]
15. Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study.
Hendriks N; Koeneman MM; van de Sande AJM; Penders CGJ; Piek JMJ; Kooreman LFS; van Kuijk SMJ; Hoosemans L; Sep SJS; de Vos Van Steenwijk PJ; van Beekhuizen HJ; Slangen BFM; Nijman HW; Kruitwagen RFPM; Kruse AJ
J Immunother; 2022 Apr; 45(3):180-186. PubMed ID: 35180719
[TBL] [Abstract][Full Text] [Related]
16. Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
Van Pachterbeke C; Bucella D; Rozenberg S; Manigart Y; Gilles C; Larsimont D; Vanden Houte K; Reynders M; Snoeck R; Bossens M
Gynecol Oncol; 2009 Oct; 115(1):69-74. PubMed ID: 19647859
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of 5% imiquimod for the treatment of Vaginal intraepithelial neoplasia-A systematic review of the literature and a meta-analysis.
Tranoulis A; Laios A; Mitsopoulos V; Lutchman-Singh K; Thomakos N
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():129-136. PubMed ID: 28985547
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
Diaz-Arrastia C; Arany I; Robazetti SC; Dinh TV; Gatalica Z; Tyring SK; Hannigan E
Clin Cancer Res; 2001 Oct; 7(10):3031-3. PubMed ID: 11595691
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia and human papilloma virus infection: A systematic review and meta-analysis of randomized clinical trials.
Zhang W; Zhang A; Sun W; Yue Y; Li H
Medicine (Baltimore); 2018 May; 97(21):e10864. PubMed ID: 29794788
[TBL] [Abstract][Full Text] [Related]
20. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.
Trimble CL; Morrow MP; Kraynyak KA; Shen X; Dallas M; Yan J; Edwards L; Parker RL; Denny L; Giffear M; Brown AS; Marcozzi-Pierce K; Shah D; Slager AM; Sylvester AJ; Khan A; Broderick KE; Juba RJ; Herring TA; Boyer J; Lee J; Sardesai NY; Weiner DB; Bagarazzi ML
Lancet; 2015 Nov; 386(10008):2078-2088. PubMed ID: 26386540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
